Table of Content

1 Human Gene Therapy Market Overview
1.1 Product Overview and Scope of Human Gene Therapy
1.2 Human Gene Therapy Segment by Type
1.2.1 Global Human Gene Therapy Market Value Comparison by Type (2024-2034)
1.2.2 Non-viral Vectors
1.2.3 Viral Vectors
1.3 Human Gene Therapy Segment by Application
1.3.1 Global Human Gene Therapy Market Value by Application: (2024-2034)
1.3.2 Neurological Diseases
1.3.3 Cancer
1.3.4 DMD (Duchenne Muscular Dystrophy)
1.3.5 Hepatological Diseases
1.3.6 Others
1.4 Global Human Gene Therapy Market Size Estimates and Forecasts
1.4.1 Global Human Gene Therapy Revenue 2018-2029
1.4.2 Global Human Gene Therapy Sales 2018-2029
1.4.3 Global Human Gene Therapy Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Human Gene Therapy Market Competition by Manufacturers
2.1 Global Human Gene Therapy Sales Market Share by Manufacturers (2018-2024)
2.2 Global Human Gene Therapy Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Human Gene Therapy Average Price by Manufacturers (2018-2024)
2.4 Global Human Gene Therapy Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Human Gene Therapy, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Human Gene Therapy, Product Type & Application
2.7 Human Gene Therapy Market Competitive Situation and Trends
2.7.1 Human Gene Therapy Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Human Gene Therapy Players Market Share by Revenue
2.7.3 Global Human Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Human Gene Therapy Retrospective Market Scenario by Region
3.1 Global Human Gene Therapy Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Human Gene Therapy Global Human Gene Therapy Sales by Region: 2018-2029
3.2.1 Global Human Gene Therapy Sales by Region: 2018-2024
3.2.2 Global Human Gene Therapy Sales by Region: 2024-2029
3.3 Global Human Gene Therapy Global Human Gene Therapy Revenue by Region: 2018-2029
3.3.1 Global Human Gene Therapy Revenue by Region: 2018-2024
3.3.2 Global Human Gene Therapy Revenue by Region: 2024-2029
3.4 North America Human Gene Therapy Market Facts & Figures by Country
3.4.1 North America Human Gene Therapy Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Human Gene Therapy Sales by Country (2018-2029)
3.4.3 North America Human Gene Therapy Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Human Gene Therapy Market Facts & Figures by Country
3.5.1 Europe Human Gene Therapy Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Human Gene Therapy Sales by Country (2018-2029)
3.5.3 Europe Human Gene Therapy Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Gene Therapy Market Facts & Figures by Country
3.6.1 Asia Pacific Human Gene Therapy Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Human Gene Therapy Sales by Country (2018-2029)
3.6.3 Asia Pacific Human Gene Therapy Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Human Gene Therapy Market Facts & Figures by Country
3.7.1 Latin America Human Gene Therapy Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Human Gene Therapy Sales by Country (2018-2029)
3.7.3 Latin America Human Gene Therapy Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Human Gene Therapy Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Gene Therapy Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Human Gene Therapy Sales by Country (2018-2029)
3.8.3 Middle East and Africa Human Gene Therapy Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Human Gene Therapy Sales by Type (2018-2029)
4.1.1 Global Human Gene Therapy Sales by Type (2018-2024)
4.1.2 Global Human Gene Therapy Sales by Type (2024-2029)
4.1.3 Global Human Gene Therapy Sales Market Share by Type (2018-2029)
4.2 Global Human Gene Therapy Revenue by Type (2018-2029)
4.2.1 Global Human Gene Therapy Revenue by Type (2018-2024)
4.2.2 Global Human Gene Therapy Revenue by Type (2024-2029)
4.2.3 Global Human Gene Therapy Revenue Market Share by Type (2018-2029)
4.3 Global Human Gene Therapy Price by Type (2018-2029)
5 Segment by Application
5.1 Global Human Gene Therapy Sales by Application (2018-2029)
5.1.1 Global Human Gene Therapy Sales by Application (2018-2024)
5.1.2 Global Human Gene Therapy Sales by Application (2024-2029)
5.1.3 Global Human Gene Therapy Sales Market Share by Application (2018-2029)
5.2 Global Human Gene Therapy Revenue by Application (2018-2029)
5.2.1 Global Human Gene Therapy Revenue by Application (2018-2024)
5.2.2 Global Human Gene Therapy Revenue by Application (2024-2029)
5.2.3 Global Human Gene Therapy Revenue Market Share by Application (2018-2029)
5.3 Global Human Gene Therapy Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Biogen
6.1.1 Biogen Corporation Information
6.1.2 Biogen Description and Business Overview
6.1.3 Biogen Human Gene Therapy Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Biogen Human Gene Therapy Product Portfolio
6.1.5 Biogen Recent Developments/Updates
6.2 Sarepta Therapeutics
6.2.1 Sarepta Therapeutics Corporation Information
6.2.2 Sarepta Therapeutics Description and Business Overview
6.2.3 Sarepta Therapeutics Human Gene Therapy Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Sarepta Therapeutics Human Gene Therapy Product Portfolio
6.2.5 Sarepta Therapeutics Recent Developments/Updates
6.3 Gilead Sciences
6.3.1 Gilead Sciences Corporation Information
6.3.2 Gilead Sciences Description and Business Overview
6.3.3 Gilead Sciences Human Gene Therapy Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Gilead Sciences Human Gene Therapy Product Portfolio
6.3.5 Gilead Sciences Recent Developments/Updates
6.4 Amgen
6.4.1 Amgen Corporation Information
6.4.2 Amgen Description and Business Overview
6.4.3 Amgen Human Gene Therapy Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Amgen Human Gene Therapy Product Portfolio
6.4.5 Amgen Recent Developments/Updates
6.5 Novartis
6.5.1 Novartis Corporation Information
6.5.2 Novartis Description and Business Overview
6.5.3 Novartis Human Gene Therapy Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Novartis Human Gene Therapy Product Portfolio
6.5.5 Novartis Recent Developments/Updates
6.6 Orchard Therapeutics
6.6.1 Orchard Therapeutics Corporation Information
6.6.2 Orchard Therapeutics Description and Business Overview
6.6.3 Orchard Therapeutics Human Gene Therapy Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Orchard Therapeutics Human Gene Therapy Product Portfolio
6.6.5 Orchard Therapeutics Recent Developments/Updates
6.7 Spark Therapeutics
6.6.1 Spark Therapeutics Corporation Information
6.6.2 Spark Therapeutics Description and Business Overview
6.6.3 Spark Therapeutics Human Gene Therapy Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Spark Therapeutics Human Gene Therapy Product Portfolio
6.7.5 Spark Therapeutics Recent Developments/Updates
6.8 Agc Biologics
6.8.1 Agc Biologics Corporation Information
6.8.2 Agc Biologics Description and Business Overview
6.8.3 Agc Biologics Human Gene Therapy Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Agc Biologics Human Gene Therapy Product Portfolio
6.8.5 Agc Biologics Recent Developments/Updates
6.9 Anges
6.9.1 Anges Corporation Information
6.9.2 Anges Description and Business Overview
6.9.3 Anges Human Gene Therapy Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Anges Human Gene Therapy Product Portfolio
6.9.5 Anges Recent Developments/Updates
6.10 Bluebird Bio
6.10.1 Bluebird Bio Corporation Information
6.10.2 Bluebird Bio Description and Business Overview
6.10.3 Bluebird Bio Human Gene Therapy Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Bluebird Bio Human Gene Therapy Product Portfolio
6.10.5 Bluebird Bio Recent Developments/Updates
6.11 Jazz Pharmaceuticals
6.11.1 Jazz Pharmaceuticals Corporation Information
6.11.2 Jazz Pharmaceuticals Human Gene Therapy Description and Business Overview
6.11.3 Jazz Pharmaceuticals Human Gene Therapy Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Jazz Pharmaceuticals Human Gene Therapy Product Portfolio
6.11.5 Jazz Pharmaceuticals Recent Developments/Updates
6.12 Dynavax Technologies
6.12.1 Dynavax Technologies Corporation Information
6.12.2 Dynavax Technologies Human Gene Therapy Description and Business Overview
6.12.3 Dynavax Technologies Human Gene Therapy Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Dynavax Technologies Human Gene Therapy Product Portfolio
6.12.5 Dynavax Technologies Recent Developments/Updates
6.13 Human Stem Cells Institute
6.13.1 Human Stem Cells Institute Corporation Information
6.13.2 Human Stem Cells Institute Human Gene Therapy Description and Business Overview
6.13.3 Human Stem Cells Institute Human Gene Therapy Sales, Revenue and Gross Margin (2018-2024)
6.13.4 Human Stem Cells Institute Human Gene Therapy Product Portfolio
6.13.5 Human Stem Cells Institute Recent Developments/Updates
6.14 Sibiono Genetech
6.14.1 Sibiono Genetech Corporation Information
6.14.2 Sibiono Genetech Human Gene Therapy Description and Business Overview
6.14.3 Sibiono Genetech Human Gene Therapy Sales, Revenue and Gross Margin (2018-2024)
6.14.4 Sibiono Genetech Human Gene Therapy Product Portfolio
6.14.5 Sibiono Genetech Recent Developments/Updates
6.15 Shanghai Sunway Biotech
6.15.1 Shanghai Sunway Biotech Corporation Information
6.15.2 Shanghai Sunway Biotech Human Gene Therapy Description and Business Overview
6.15.3 Shanghai Sunway Biotech Human Gene Therapy Sales, Revenue and Gross Margin (2018-2024)
6.15.4 Shanghai Sunway Biotech Human Gene Therapy Product Portfolio
6.15.5 Shanghai Sunway Biotech Recent Developments/Updates
6.16 Uniqure N.V.
6.16.1 Uniqure N.V. Corporation Information
6.16.2 Uniqure N.V. Human Gene Therapy Description and Business Overview
6.16.3 Uniqure N.V. Human Gene Therapy Sales, Revenue and Gross Margin (2018-2024)
6.16.4 Uniqure N.V. Human Gene Therapy Product Portfolio
6.16.5 Uniqure N.V. Recent Developments/Updates
6.17 Gensight Biologics S.A.
6.17.1 Gensight Biologics S.A. Corporation Information
6.17.2 Gensight Biologics S.A. Human Gene Therapy Description and Business Overview
6.17.3 Gensight Biologics S.A. Human Gene Therapy Sales, Revenue and Gross Margin (2018-2024)
6.17.4 Gensight Biologics S.A. Human Gene Therapy Product Portfolio
6.17.5 Gensight Biologics S.A. Recent Developments/Updates
6.18 Celgene Corporation
6.18.1 Celgene Corporation Corporation Information
6.18.2 Celgene Corporation Human Gene Therapy Description and Business Overview
6.18.3 Celgene Corporation Human Gene Therapy Sales, Revenue and Gross Margin (2018-2024)
6.18.4 Celgene Corporation Human Gene Therapy Product Portfolio
6.18.5 Celgene Corporation Recent Developments/Updates
6.19 Cellectis
6.19.1 Cellectis Corporation Information
6.19.2 Cellectis Human Gene Therapy Description and Business Overview
6.19.3 Cellectis Human Gene Therapy Sales, Revenue and Gross Margin (2018-2024)
6.19.4 Cellectis Human Gene Therapy Product Portfolio
6.19.5 Cellectis Recent Developments/Updates
6.20 Sangamo Therapeutics
6.20.1 Sangamo Therapeutics Corporation Information
6.20.2 Sangamo Therapeutics Human Gene Therapy Description and Business Overview
6.20.3 Sangamo Therapeutics Human Gene Therapy Sales, Revenue and Gross Margin (2018-2024)
6.20.4 Sangamo Therapeutics Human Gene Therapy Product Portfolio
6.20.5 Sangamo Therapeutics Recent Developments/Updates
6.21 Mustang Bio
6.21.1 Mustang Bio Corporation Information
6.21.2 Mustang Bio Human Gene Therapy Description and Business Overview
6.21.3 Mustang Bio Human Gene Therapy Sales, Revenue and Gross Margin (2018-2024)
6.21.4 Mustang Bio Human Gene Therapy Product Portfolio
6.21.5 Mustang Bio Recent Developments/Updates
6.22 AGTC
6.22.1 AGTC Corporation Information
6.22.2 AGTC Human Gene Therapy Description and Business Overview
6.22.3 AGTC Human Gene Therapy Sales, Revenue and Gross Margin (2018-2024)
6.22.4 AGTC Human Gene Therapy Product Portfolio
6.22.5 AGTC Recent Developments/Updates
6.23 Poseida Therapeutics
6.23.1 Poseida Therapeutics Corporation Information
6.23.2 Poseida Therapeutics Human Gene Therapy Description and Business Overview
6.23.3 Poseida Therapeutics Human Gene Therapy Sales, Revenue and Gross Margin (2018-2024)
6.23.4 Poseida Therapeutics Human Gene Therapy Product Portfolio
6.23.5 Poseida Therapeutics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Gene Therapy Industry Chain Analysis
7.2 Human Gene Therapy Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Gene Therapy Production Mode & Process
7.4 Human Gene Therapy Sales and Marketing
7.4.1 Human Gene Therapy Sales Channels
7.4.2 Human Gene Therapy Distributors
7.5 Human Gene Therapy Customers
8 Human Gene Therapy Market Dynamics
8.1 Human Gene Therapy Industry Trends
8.2 Human Gene Therapy Market Drivers
8.3 Human Gene Therapy Market Challenges
8.4 Human Gene Therapy Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Human Gene Therapy Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Human Gene Therapy Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Human Gene Therapy Market Competitive Situation by Manufacturers in 2022
Table 4. Global Human Gene Therapy Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Human Gene Therapy Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Human Gene Therapy Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Human Gene Therapy Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Human Gene Therapy Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Human Gene Therapy, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Human Gene Therapy, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Human Gene Therapy, Product Type & Application
Table 12. Global Key Manufacturers of Human Gene Therapy, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Human Gene Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Gene Therapy as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Human Gene Therapy Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Human Gene Therapy Sales by Region (2018-2024) & (K Units)
Table 18. Global Human Gene Therapy Sales Market Share by Region (2018-2024)
Table 19. Global Human Gene Therapy Sales by Region (2024-2029) & (K Units)
Table 20. Global Human Gene Therapy Sales Market Share by Region (2024-2029)
Table 21. Global Human Gene Therapy Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Human Gene Therapy Revenue Market Share by Region (2018-2024)
Table 23. Global Human Gene Therapy Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Human Gene Therapy Revenue Market Share by Region (2024-2029)
Table 25. North America Human Gene Therapy Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Human Gene Therapy Sales by Country (2018-2024) & (K Units)
Table 27. North America Human Gene Therapy Sales by Country (2024-2029) & (K Units)
Table 28. North America Human Gene Therapy Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Human Gene Therapy Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Human Gene Therapy Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Human Gene Therapy Sales by Country (2018-2024) & (K Units)
Table 32. Europe Human Gene Therapy Sales by Country (2024-2029) & (K Units)
Table 33. Europe Human Gene Therapy Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Human Gene Therapy Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Human Gene Therapy Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Human Gene Therapy Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Human Gene Therapy Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Human Gene Therapy Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Human Gene Therapy Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Human Gene Therapy Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Human Gene Therapy Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Human Gene Therapy Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Human Gene Therapy Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Human Gene Therapy Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Human Gene Therapy Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Human Gene Therapy Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Human Gene Therapy Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Human Gene Therapy Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Human Gene Therapy Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Human Gene Therapy Sales (K Units) by Type (2018-2024)
Table 51. Global Human Gene Therapy Sales (K Units) by Type (2024-2029)
Table 52. Global Human Gene Therapy Sales Market Share by Type (2018-2024)
Table 53. Global Human Gene Therapy Sales Market Share by Type (2024-2029)
Table 54. Global Human Gene Therapy Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Human Gene Therapy Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Human Gene Therapy Revenue Market Share by Type (2018-2024)
Table 57. Global Human Gene Therapy Revenue Market Share by Type (2024-2029)
Table 58. Global Human Gene Therapy Price (US$/Unit) by Type (2018-2024)
Table 59. Global Human Gene Therapy Price (US$/Unit) by Type (2024-2029)
Table 60. Global Human Gene Therapy Sales (K Units) by Application (2018-2024)
Table 61. Global Human Gene Therapy Sales (K Units) by Application (2024-2029)
Table 62. Global Human Gene Therapy Sales Market Share by Application (2018-2024)
Table 63. Global Human Gene Therapy Sales Market Share by Application (2024-2029)
Table 64. Global Human Gene Therapy Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Human Gene Therapy Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Human Gene Therapy Revenue Market Share by Application (2018-2024)
Table 67. Global Human Gene Therapy Revenue Market Share by Application (2024-2029)
Table 68. Global Human Gene Therapy Price (US$/Unit) by Application (2018-2024)
Table 69. Global Human Gene Therapy Price (US$/Unit) by Application (2024-2029)
Table 70. Biogen Corporation Information
Table 71. Biogen Description and Business Overview
Table 72. Biogen Human Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Biogen Human Gene Therapy Product
Table 74. Biogen Recent Developments/Updates
Table 75. Sarepta Therapeutics Corporation Information
Table 76. Sarepta Therapeutics Description and Business Overview
Table 77. Sarepta Therapeutics Human Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. Sarepta Therapeutics Human Gene Therapy Product
Table 79. Sarepta Therapeutics Recent Developments/Updates
Table 80. Gilead Sciences Corporation Information
Table 81. Gilead Sciences Description and Business Overview
Table 82. Gilead Sciences Human Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. Gilead Sciences Human Gene Therapy Product
Table 84. Gilead Sciences Recent Developments/Updates
Table 85. Amgen Corporation Information
Table 86. Amgen Description and Business Overview
Table 87. Amgen Human Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. Amgen Human Gene Therapy Product
Table 89. Amgen Recent Developments/Updates
Table 90. Novartis Corporation Information
Table 91. Novartis Description and Business Overview
Table 92. Novartis Human Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. Novartis Human Gene Therapy Product
Table 94. Novartis Recent Developments/Updates
Table 95. Orchard Therapeutics Corporation Information
Table 96. Orchard Therapeutics Description and Business Overview
Table 97. Orchard Therapeutics Human Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. Orchard Therapeutics Human Gene Therapy Product
Table 99. Orchard Therapeutics Recent Developments/Updates
Table 100. Spark Therapeutics Corporation Information
Table 101. Spark Therapeutics Description and Business Overview
Table 102. Spark Therapeutics Human Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. Spark Therapeutics Human Gene Therapy Product
Table 104. Spark Therapeutics Recent Developments/Updates
Table 105. Agc Biologics Corporation Information
Table 106. Agc Biologics Description and Business Overview
Table 107. Agc Biologics Human Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. Agc Biologics Human Gene Therapy Product
Table 109. Agc Biologics Recent Developments/Updates
Table 110. Anges Corporation Information
Table 111. Anges Description and Business Overview
Table 112. Anges Human Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. Anges Human Gene Therapy Product
Table 114. Anges Recent Developments/Updates
Table 115. Bluebird Bio Corporation Information
Table 116. Bluebird Bio Description and Business Overview
Table 117. Bluebird Bio Human Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Bluebird Bio Human Gene Therapy Product
Table 119. Bluebird Bio Recent Developments/Updates
Table 120. Jazz Pharmaceuticals Corporation Information
Table 121. Jazz Pharmaceuticals Description and Business Overview
Table 122. Jazz Pharmaceuticals Human Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Jazz Pharmaceuticals Human Gene Therapy Product
Table 124. Jazz Pharmaceuticals Recent Developments/Updates
Table 125. Dynavax Technologies Corporation Information
Table 126. Dynavax Technologies Description and Business Overview
Table 127. Dynavax Technologies Human Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. Dynavax Technologies Human Gene Therapy Product
Table 129. Dynavax Technologies Recent Developments/Updates
Table 130. Human Stem Cells Institute Corporation Information
Table 131. Human Stem Cells Institute Description and Business Overview
Table 132. Human Stem Cells Institute Human Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. Human Stem Cells Institute Human Gene Therapy Product
Table 134. Human Stem Cells Institute Recent Developments/Updates
Table 135. Sibiono Genetech Corporation Information
Table 136. Sibiono Genetech Description and Business Overview
Table 137. Sibiono Genetech Human Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 138. Sibiono Genetech Human Gene Therapy Product
Table 139. Sibiono Genetech Recent Developments/Updates
Table 140. Shanghai Sunway Biotech Corporation Information
Table 141. Shanghai Sunway Biotech Description and Business Overview
Table 142. Shanghai Sunway Biotech Human Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 143. Shanghai Sunway Biotech Human Gene Therapy Product
Table 144. Shanghai Sunway Biotech Recent Developments/Updates
Table 145. Uniqure N.V. Corporation Information
Table 146. Uniqure N.V. Description and Business Overview
Table 147. Uniqure N.V. Human Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 148. Uniqure N.V. Human Gene Therapy Product
Table 149. Uniqure N.V. Recent Developments/Updates
Table 150. Gensight Biologics S.A. Corporation Information
Table 151. Gensight Biologics S.A. Description and Business Overview
Table 152. Gensight Biologics S.A. Human Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 153. Gensight Biologics S.A. Human Gene Therapy Product
Table 154. Gensight Biologics S.A. Recent Developments/Updates
Table 155. Celgene Corporation Corporation Information
Table 156. Celgene Corporation Description and Business Overview
Table 157. Celgene Corporation Human Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 158. Celgene Corporation Human Gene Therapy Product
Table 159. Celgene Corporation Recent Developments/Updates
Table 160. Cellectis Corporation Information
Table 161. Cellectis Description and Business Overview
Table 162. Cellectis Human Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 163. Cellectis Human Gene Therapy Product
Table 164. Cellectis Recent Developments/Updates
Table 165. Sangamo Therapeutics Corporation Information
Table 166. Sangamo Therapeutics Description and Business Overview
Table 167. Sangamo Therapeutics Human Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 168. Sangamo Therapeutics Human Gene Therapy Product
Table 169. Sangamo Therapeutics Recent Developments/Updates
Table 170. Mustang Bio Corporation Information
Table 171. Mustang Bio Description and Business Overview
Table 172. Mustang Bio Human Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 173. Mustang Bio Human Gene Therapy Product
Table 174. Mustang Bio Recent Developments/Updates
Table 175. AGTC Corporation Information
Table 176. AGTC Description and Business Overview
Table 177. AGTC Human Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 178. AGTC Human Gene Therapy Product
Table 179. AGTC Recent Developments/Updates
Table 180. Poseida Therapeutics Corporation Information
Table 181. Poseida Therapeutics Description and Business Overview
Table 182. Poseida Therapeutics Human Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 183. Poseida Therapeutics Human Gene Therapy Product
Table 184. Poseida Therapeutics Recent Developments/Updates
Table 185. Key Raw Materials Lists
Table 186. Raw Materials Key Suppliers Lists
Table 187. Human Gene Therapy Distributors List
Table 188. Human Gene Therapy Customers List
Table 189. Human Gene Therapy Market Trends
Table 190. Human Gene Therapy Market Drivers
Table 191. Human Gene Therapy Market Challenges
Table 192. Human Gene Therapy Market Restraints
Table 193. Research Programs/Design for This Report
Table 194. Key Data Information from Secondary Sources
Table 195. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Human Gene Therapy
Figure 2. Global Human Gene Therapy Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Human Gene Therapy Market Share by Type in 2022 & 2029
Figure 4. Non-viral Vectors Product Picture
Figure 5. Viral Vectors Product Picture
Figure 6. Global Human Gene Therapy Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Human Gene Therapy Market Share by Application in 2022 & 2029
Figure 8. Neurological Diseases
Figure 9. Cancer
Figure 10. DMD (Duchenne Muscular Dystrophy)
Figure 11. Hepatological Diseases
Figure 12. Others
Figure 13. Global Human Gene Therapy Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Human Gene Therapy Market Size (2018-2029) & (US$ Million)
Figure 15. Global Human Gene Therapy Sales (2018-2029) & (K Units)
Figure 16. Global Human Gene Therapy Average Price (US$/Unit) & (2018-2029)
Figure 17. Human Gene Therapy Report Years Considered
Figure 18. Human Gene Therapy Sales Share by Manufacturers in 2022
Figure 19. Global Human Gene Therapy Revenue Share by Manufacturers in 2022
Figure 20. The Global 5 and 10 Largest Human Gene Therapy Players: Market Share by Revenue in 2022
Figure 21. Human Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 22. Global Human Gene Therapy Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 23. North America Human Gene Therapy Sales Market Share by Country (2018-2029)
Figure 24. North America Human Gene Therapy Revenue Market Share by Country (2018-2029)
Figure 25. United States Human Gene Therapy Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Canada Human Gene Therapy Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Europe Human Gene Therapy Sales Market Share by Country (2018-2029)
Figure 28. Europe Human Gene Therapy Revenue Market Share by Country (2018-2029)
Figure 29. Germany Human Gene Therapy Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. France Human Gene Therapy Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. U.K. Human Gene Therapy Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Italy Human Gene Therapy Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Russia Human Gene Therapy Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Asia Pacific Human Gene Therapy Sales Market Share by Region (2018-2029)
Figure 35. Asia Pacific Human Gene Therapy Revenue Market Share by Region (2018-2029)
Figure 36. China Human Gene Therapy Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Japan Human Gene Therapy Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. South Korea Human Gene Therapy Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. India Human Gene Therapy Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Australia Human Gene Therapy Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. China Taiwan Human Gene Therapy Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Indonesia Human Gene Therapy Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Thailand Human Gene Therapy Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Malaysia Human Gene Therapy Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Latin America Human Gene Therapy Sales Market Share by Country (2018-2029)
Figure 46. Latin America Human Gene Therapy Revenue Market Share by Country (2018-2029)
Figure 47. Mexico Human Gene Therapy Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Brazil Human Gene Therapy Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Argentina Human Gene Therapy Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Middle East & Africa Human Gene Therapy Sales Market Share by Country (2018-2029)
Figure 51. Middle East & Africa Human Gene Therapy Revenue Market Share by Country (2018-2029)
Figure 52. Turkey Human Gene Therapy Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Human Gene Therapy Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. UAE Human Gene Therapy Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Global Sales Market Share of Human Gene Therapy by Type (2018-2029)
Figure 56. Global Revenue Market Share of Human Gene Therapy by Type (2018-2029)
Figure 57. Global Human Gene Therapy Price (US$/Unit) by Type (2018-2029)
Figure 58. Global Sales Market Share of Human Gene Therapy by Application (2018-2029)
Figure 59. Global Revenue Market Share of Human Gene Therapy by Application (2018-2029)
Figure 60. Global Human Gene Therapy Price (US$/Unit) by Application (2018-2029)
Figure 61. Human Gene Therapy Value Chain
Figure 62. Human Gene Therapy Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed